PharmaJet® teaming up with Universities for Needle-free Flu Shot Clinics

Golden, Co. — July 19, 2016 — PharmaJet, the maker of innovative, needle-free injection technology, announced that Needle-free flu shots will be offered at multiple universities this fall including the University of the Pacific in Stockton, California.

“We are excited to be offering the PharmaJet needle-free flu shots this year as part of our on- and off-campus clinics, providing our staff, faculty, students and the greater off-campus community a needle-free option,” said Mark Walberg, PharmD, PhD, CTH, Associate Professor of Pharmacy Practice.

“This is the third year that we have offered needle-free flu shots in university clinics. This year we are expanding nationwide. In addition, use of the PharmaJet device is included in the curriculum at over 100 of the top Pharmacy school programs. Providers like the simplicity and ease-of-use of the PharmaJet device and many have found that they can attract new patients and increase immunization rates. Needle-free has a broad appeal and offers a safe, fast and easy method of getting a flu shot. Ninety-three percent of people that have received a needle-free flu shot say they would choose it again¹,” said Ron Lowy, Chairman and Chief Executive Officer, PharmaJet Inc.

For more information on PharmaJet’s Needle-free technology and how to set up a needle-free flu clinic at your university or company, please visit www.pharmajet.com.

Refer to Instructions for Use to ensure safe injections and to review risks.

About PharmaJet

Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market. PharmaJet’s devices are also integral in the development of multiple novel pharmaceuticals. The innovative Stratis^® device has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis^® device was cleared for delivery of an influenza vaccine to deliver needle-free flu shots. The Tropis^® device for intradermal injections received CE marketing clearance in 2016. The PharmaJet needle-free devices are safe, fast and easy-to-use. They eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal. For more information, visit www.pharmajet.com.

¹ PharmaJet, Inc. (2014) 61-10201 Post Market Surveillance – internal company report, February, 2015.